Related Experiment Video
Updated: Jun 8, 2026
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
Molecular diagnosis of genetic iron-overload disorders
Pierre Brissot1, Edouard Bardou-Jacquet, Marie-Bérengère Troadec
1Liver Disease Unit, INSERM U-991, National Reference Center for Genetic Iron Overload and Laboratory of Molecular Genetics Hôpital Pontchaillou, Rue Henri Le Guilloux, Rennes, France. pierre.brissot@univ-rennes1.fr
Insights
Genetic iron overload involves more than HFE C282Y mutations. Discoveries reveal new genetic hemochromatosis types, expanding diagnosis and potential therapies beyond classical forms.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Classical hemochromatosis is linked to HFE C282Y mutations, common in Caucasians.
- This mutation is not the only cause of genetic iron overload.
- Other HFE and novel gene mutations cause less common types (2, 3, 4) affecting diverse populations.
Purpose of the Study:
- To review the evolving understanding of genetic iron overload.
- To highlight the discovery of novel genetic mutations beyond HFE C282Y.
- To emphasize the role of molecular diagnostics in identifying diverse hemochromatosis types.
Main Methods:
- Literature review of genetic iron overload disorders.
- Analysis of genetic mutations associated with hemochromatosis types 1-4.
- Discussion of diagnostic and therapeutic implications.
Main Results:
- HFE C282Y is the most frequent cause of genetic iron overload (Type 1 Hemochromatosis).
- Novel mutations in HFE and other genes define Types 2, 3, and 4 hemochromatosis.
- These rarer forms are not restricted to Caucasian populations.
Conclusions:
- Genetic iron overload encompasses multiple HFE and non-HFE related conditions.
- Molecular diagnostics are crucial for accurate identification of different hemochromatosis types.
- Future research may yield new diagnostic markers and targeted therapies.
Abstract:
Genetic iron overload has long been confined to the picture of classical hemochromatosis related to the HFE C282Y mutation (type 1 hemochromatosis). C282Y homozygosity affects approximately three people out of 1000 of the Caucasian population, representing one of the most frequent genetic predispositions. It has, however, rapidly become clear that the HFE C282Y mutation is not the sole culprit in genetic iron overload. Several novel mutations in HFE and other genes have been discovered and related to various entities, which are now known as types 2, 3 and 4 hemochromatosis. These diseases are far less frequent than the classical type 1 hemochromatosis but, by contrast, are not limited to the Caucasian population. Molecular diagnosis obviously plays a key role in the diagnostic strategy. In the future, it will undoubtedly enable not only identification of new diagnostic markers, but also provide potential molecular targets for pathophysiologically based innovative therapeutic approaches.
Related Concept Videos
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life